(ARWR) Arrowhead - Performance -35.5% in 12m
ARWR performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-77.80%
#126 in Peer-Group
Rel. Strength
15.09%
#6526 in Stock-Universe
Total Return 12m
-35.52%
#103 in Peer-Group
Total Return 5y
-62.04%
#72 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 111 |
| High / Low | USD |
|---|---|
| 52 Week High | 29.54 USD |
| 52 Week Low | 9.99 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 93.46 |
| Buy/Sell Signal +-5 | 0.40 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ARWR (-35.5%) vs XBI (-11.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.14% | 63.4% | 78.7% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
3.16% | -9.04% | 157% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.5% | -7.13% | 36% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
8.1% | -8.36% | 1.32% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-0.99% | 26.5% | -5.28% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
8.81% | 38.5% | -10.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.65% | 49.3% | -10.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.76% | 27.6% | 14.6% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ARWR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARWR
| Total Return (including Dividends) | ARWR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 18.54% | 5.89% | 3.98% |
| 3 Months | 50.81% | 15.34% | 16.24% |
| 12 Months | -35.52% | -11.61% | 12.66% |
| 5 Years | -62.04% | -23.80% | 109.18% |
| Trend Score (consistency of price movement) | ARWR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 81.7% | 65.7% | 91.4% |
| 3 Months | 86.9% | 79.4% | 97.5% |
| 12 Months | -81.8% | -87.3% | 46.7% |
| 5 Years | -91.2% | -51.8% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th80.00 | 11.95% | 14.00% |
| 3 Month | %th77.50 | 30.76% | 29.74% |
| 12 Month | %th48.50 | -27.04% | -42.76% |
| 5 Years | %th64.50 | -50.18% | -81.85% |
FAQs
Does Arrowhead (ARWR) outperform the market?
No,
over the last 12 months ARWR made -35.52%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.61%.
Over the last 3 months ARWR made 50.81%, while XBI made 15.34%.
Performance Comparison ARWR vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ARWR vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 9.8% | 14.6% | -4.9% | -48% |
| US NASDAQ 100 | QQQ | 9.8% | 14.3% | -7.3% | -48% |
| German DAX 40 | DAX | 10.1% | 16.6% | -15.5% | -65% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 8.3% | 13.4% | -6.8% | -55% |
| Hongkong Hang Seng | HSI | 9.1% | 16% | -26.2% | -70% |
| India NIFTY 50 | INDA | 11.3% | 17.9% | -4.7% | -32% |
| Brasil Bovespa | EWZ | 15% | 22.1% | -18% | -35% |
ARWR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 10.5% | 15.7% | -9.6% | -60% |
| Consumer Discretionary | XLY | 8.8% | 14.5% | 2.3% | -53% |
| Consumer Staples | XLP | 12% | 18.3% | -3.9% | -43% |
| Energy | XLE | 8.2% | 17.4% | 4.9% | -35% |
| Financial | XLF | 10.8% | 14.2% | -6.6% | -60% |
| Health Care | XLV | 10% | 18.6% | 5.8% | -28% |
| Industrial | XLI | 9.1% | 13.1% | -9.9% | -58% |
| Materials | XLB | 9.9% | 14.7% | -3.5% | -38% |
| Real Estate | XLRE | 9.6% | 17.8% | -3.1% | -43% |
| Technology | XLK | 10.2% | 13.2% | -9.5% | -45% |
| Utilities | XLU | 9.6% | 15.7% | -7.8% | -58% |
| Aerospace & Defense | XAR | 7.5% | 8.6% | -25.4% | -85% |
| Biotech | XBI | 4.9% | 12.7% | 1.2% | -24% |
| Homebuilder | XHB | 7.7% | 9.2% | 5.4% | -32% |
| Retail | XRT | 9.4% | 13.4% | -1.6% | -43% |
ARWR vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 11.6% | 22.3% | 10.5% | -30% |
| Natural Gas | UNG | 9.3% | 28.5% | 20.3% | -41% |
| Gold | GLD | 10.3% | 19.8% | -21.6% | -73% |
| Silver | SLV | 6.9% | 13.7% | -24.2% | -59% |
| Copper | CPER | 0.5% | 5% | -22.7% | -58% |
ARWR vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 11.1% | 18% | 0.6% | -32% |
| iShares High Yield Corp. Bond | HYG | 10.5% | 17.4% | -1.7% | -44% |